A Histopathological Study of Ovarian Lesions

Abstract

BACKGROUNDTumours of the ovary are common and form the third most common tumours of female genital tract next to carcinoma cervix and endometrium. Patients usually present at an advanced stage and pose difficulties to clinician as lab workup has limited role. A histopathological study is a must for final diagnosis.The study was conducted with an aim to find the incidence of non-neoplastic and neoplastic lesions of the ovary with respect to age, reproductive period, use of OCPs and laterality. An attempt was made to study the histopathological diagnosis of the nature of the non-neoplastic lesion and in case of neoplastic lesions their origin and benign or malignant nature. Also, the prognosis in case of malignant lesions was assessed by considering the microscopic grading. MATERIALS AND METHODSThis was a descriptive study over 18 months' duration. All surgically resected ovarian specimens were received. Relevant data like history of OCP and laterality of lesion were recorded. They were grossed, processed, examined and categorised as non-neoplastic and neoplastic lesion. RESULTSOut of 148 ovarian lesions studied, 98 were non-neoplastic and 50 were neoplastic. Among non-neoplastic lesions follicular cysts were common, reduction in luteal cysts were noted. Among neoplastic lesions, benign were common. On grading the six malignant lesions, five were grade 1 and one case was grade 3. CONCLUSIONNon-neoplastic and benign lesions overshadow the malignant ovarian tumours. However, nonspecific symptomatology in malignant tumours of ovary portends a need for early detection and surgical intervention for better outcome.

Diversity of Ovarian Tumors An Institutional Study

“…Benign tumors constituted 89.09% cases, borderline were 7.04% and malignant were 9.8% cases in the present study. Similar results were also observed in studies by Puttaveerachary A et al [18], Wills V et al [19]and Badge A et al [20]Out of 71 ovarian tumors surface epithelial tumors were most common comprising 60.5% cases followed by germ cell tumors 33.8% cases and sex cord stromal tumor 5.6% cases.…”